Article,

Cancer transcriptome profiling at the juncture of clinical translation

, and .
Nature Reviews Genetics, 19 (2): 93--109 (2018)
DOI: 10.1038/nrg.2017.96

Abstract

RNA sequencing (RNA-seq) has the potential to bridge tumour genotypes (for example, mutations) and their phenotypic consequences (for example, cancer molecular subtypes).The field of transcriptomics has matured thanks to lockstep developments in experimental protocols, algorithms and databases.Methodological and algorithmic advances continue to enable clinical applications of transcriptome profiling.Detection of gene fusions is the most immediate application of RNA-seq.Gene expression signatures have demonstrated prognostic and predictive value.Transcriptome profiling will be essential for immuno-oncology.

Tags

Users

  • @marcsaric

Comments and Reviews